Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Biological Procedures Online

Fig. 5

From: Development of an Interpretable Deep Learning Model for Pathological Tumor Response Assessment After Neoadjuvant Therapy

Fig. 5

a Comparative assessment of residual tumor percentage by different analytical approaches versus expert consensus ground truth. b Assessment of model-predicted residual tumor percentages against ground truth measurements across two study cohorts. The performance remained notable on the external Cohort 2 test set, showing satisfactory generalizability of our approach to new histological specimens. c Scatter plots comparing viable tumor percentage predictions for example patients from human experts and the deep learning model, illustrating general concordance between automated and manual assessment methods

Back to article page